Pharmacotherapy for resistant hypertension in adults-Reference-Cited by-同舟云学术

Pharmacotherapy for resistant hypertension in adults

Published:2017-08-23 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Charan Jaykaran¹,Chaudhari Mayur²,Mulla Summaiya³,Reljic Tea⁴,Mhaskar Rahul⁴,Kumar Ambuj⁴

Affiliation:

1. All India Institute of Medical Sciences Jodhpur; Department of Pharmacology; Basni Phase II Jodhpur Rajasthan India 342005

2. Govt. Medical College; Department of Pharmacology; Outside Majura gate Surat Gujarat India 395001

3. Govt. Medical College; Department of Microbiology; Outside Majura gate Surat Gujarat India 395001

4. University of South Florida; Center for Evidence Based Medicine and Health Outcomes Research; 12901 Bruce B. Downs Blvd., MDC27 Tampa Florida USA 33612

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012769/epdf/full

Reference48 articles.

1. Efficacy of low dose spironolactone in chronic kidney disease with resistant hypertension;Abolghasmi;Saudi Journal of Kidney Disease and Transplantation,2011

2. GRADE guidelines: 3. Rating the quality of evidence;Balshem;Journal of Clinical Epidemiology,2011

3. Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study;Black;Journal of Clinical Hypertension (Greenwich, Conn.),2007

4. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research;Calhoun;Hypertension,2008

5. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure;Chobanian;Hypertension,2003